NAD+ Study 1

We are seeking 16 participants for the next round of testing for a new formulation for NAD+ support. This will be a 3-week study and the product will be packaged in capsules. They will be provided with NAD+ product and instructed to take in the morning with a large glass of water (or other beverage) following a five day dosing and two day off schedule.  They will be asked to take the questionnaire in the evening of their first dose, after using for 5 days, after 2 weeks, and after 3 weeks.

Participation Requirements:

  • To not begin taking any new supplements while testing this product and continue taking any supplements they are currently using regularly. 

  • Willingness to complete questionnaires, records, and diaries associated with the study.

Exclusion Criteria:

  • Women who are pregnant, breastfeeding, or planning to become pregnant during the trial

  • Known food intolerances/allergy to any ingredients in the product

  • Having any of the following conditions: Psychiatric conditions, neurologic disorders, high blood pressure, heart conditions, endocrine disorders, cancer

  • Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines

  • On immunosuppressive therapy

  • Vegan, since we can’t guarantee that all ingredients will be vegan for this project.

This beta test has been completed